Suênia da Cunha Gonçalves de Albuquerque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suênia da Cunha Gonçalves de Albuquerque has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Milena de Paiva-Cavalcanti
Fundação Oswaldo Cruz, Brasil
7 shared publications - Lays Adrianne Mendonça Trajano-Silva
Department of Cell and Molecular Biology and Pathogenic Bioagents - Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto, Brazil
6 shared publications - Rayana Carla Silva de Morais
Aggeu Magalhães Institute, FIOCRUZ-PE, Rego Avenue, University City, Recife-Pernambuco, 50670-420, Brazil
5 shared publications - Maria Carolina Accioly Brelaz de Castro
Núcleo de Enfermagem, Centro Acadêmico de Vitória, Universidade Federal de Pernambuco, Vitória de Santo Antão, Brazil
3 shared publications - Rômulo Pessoa-E-Silva
Aggeu Magalhães Institute, Recife, Pernambuco, Brazil
3 shared publications - Romulo Pessoa-E-Silva
Oswaldo Cruz Foundation
2 shared publications
Latest Publications
- 11 April 2022
- Published by Elsevier in Acta Tropica
- Vol. 232, 106452
Exploring IL-17 gene promoter polymorphisms in canine leishmaniasis
- 11 April 2022
- Published by Elsevier in Acta Tropica
- Vol. 232, 106452
Exploring IL-17 gene promoter polymorphisms in canine leishmaniasis
- 1 October 2019
- Published by Elsevier in Experimental Cell Research
- Vol. 383 (2) , 111560
The effects of endoplasmic reticulum stressors, tunicamycin and dithiothreitol on Trypanosoma cruzi
- 1 October 2019
- Published by Elsevier in Experimental Cell Research
- Vol. 383 (2) , 111560
The effects of endoplasmic reticulum stressors, tunicamycin and dithiothreitol on Trypanosoma cruzi
- 26 December 2017
- Published by Bentham Science Publishers Ltd.
- p. 88-113
Vaccines Against Trypanosomatids
- 26 December 2017
- Published by Bentham Science Publishers Ltd.
- p. 88-113
Vaccines Against Trypanosomatids
- Open Access
- 30 October 2017
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1437
The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis
Advances in the understanding of leishmaniasis progression indicate that cellular interactions more complex than the Th1/Th2 paradigmdefine the course of infection. Th17 cells are a crucial modulator of adaptive immunity against Leishmania parasites acting mainly on neutrophil recruitment and playing a dual role at the site of infection. This review describes the roles of both these cell typesin linking innate defenseresponses to the establishment of specific immunity. We focus on the Th17–neutrophil interaction as a crucial component of anti-Leishmania immunity, and the clinical evolution of cutaneous or visceral leishmaniasis.To date, information obtained through experimental models and patient evaluations suggests that the influence of the presence of interleukin (IL)-17 (the main cytokine produced by Th17 cells) and neutrophilsduring Leishmania infections is strictly dependent on the tissue (skin or liver/spleen) and parasite species. Also, the time at which neutrophils are recruited, and the persistence of IL-17 in the infection microenvironment, may also be significant. A clearer understanding of these interactionswill enable better measurement ofthe influence of IL-17 and its regulators,and contribute to the identification of disease/resistance biomarkers.
- 30 October 2017
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1437
Open AccessThe Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis
Advances in the understanding of leishmaniasis progression indicate that cellular interactions more complex than the Th1/Th2 paradigmdefine the course of infection. Th17 cells are a crucial modulator of adaptive immunity against Leishmania parasites acting mainly on neutrophil recruitment and playing a dual role at the site of infection. This review describes the roles of both these cell typesin linking innate defenseresponses to the establishment of specific immunity. We focus on the Th17–neutrophil interaction as a crucial component of anti-Leishmania immunity, and the clinical evolution of cutaneous or visceral leishmaniasis.To date, information obtained through experimental models and patient evaluations suggests that the influence of the presence of interleukin (IL)-17 (the main cytokine produced by Th17 cells) and neutrophilsduring Leishmania infections is strictly dependent on the tissue (skin or liver/spleen) and parasite species. Also, the time at which neutrophils are recruited, and the persistence of IL-17 in the infection microenvironment, may also be significant. A clearer understanding of these interactionswill enable better measurement ofthe influence of IL-17 and its regulators,and contribute to the identification of disease/resistance biomarkers.
- 1 December 2016
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 131, 34-41
Evaluation of urine for Leishmania infantum DNA detection by real-time quantitative PCR
- 1 December 2016
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 131, 34-41
Evaluation of urine for Leishmania infantum DNA detection by real-time quantitative PCR
- 1 June 2016
- Published by Elsevier in Microbial Pathogenesis
- Vol. 95, 68-76
Neonatal malnutrition programs the oxidant function of macrophages in response to Candida albicans
- 1 June 2016
- Published by Elsevier in Microbial Pathogenesis
- Vol. 95, 68-76
Neonatal malnutrition programs the oxidant function of macrophages in response to Candida albicans
- 1 June 2016
- Published by Elsevier in Experimental Parasitology
- Vol. 165, 43-50
Real-time PCR for Leishmania species identification: Evaluation and comparison with classical techniques
- 1 June 2016
- Published by Elsevier in Experimental Parasitology
- Vol. 165, 43-50
Real-time PCR for Leishmania species identification: Evaluation and comparison with classical techniques
- Open Access
- 17 June 2015
- Published by Springer Nature in Cell & Bioscience
- Vol. 5 (1) , 1-10
Leishmaniases diagnosis: an update on the use of immunological and molecular tools
Leishmaniases are caused by obligate intracellular protozoan parasites of the genus Leishmania. They cause a spectrum of diseases, most notably visceral (VL), cutaneous (CL), and mucosal (ML) leishmaniasis, which affect millions of people around the world, each year. Despite scientific advances, leishmaniases cases are expanding, constituting an important public health problem. Immunological and molecular diagnostic tools have been increasingly applied for the early detection of these parasitic infections, since the existence of limitations in clinical and parasitological examinations may provide false results, thus interfering in epidemiological research and diseases control. Although there is a great diversity of available immunological assays, important common deficiencies persist, which explains the current exploration of the molecular biology in research fields, especially the Polymerase Chain Reaction (PCR) and its variants, such as real-time quantitative PCR. However, in the last years, significant results have also been reached inside of immunological context (especially by Flow Cytometry), for humans and dogs, demonstrated by research works of the New and Old worlds. In spite of their potential to clarify and minimize the present global situation of the diseases, the implementation of molecular or immunological innovative reference assays for VL and CL at health services is still a challenge due to several reasons, including lack of standardization among laboratories and structural concerns. In this article we bring classical and current information about technological advances for the immunological and molecular leishmaniases diagnosis, their features, and applications.
- 17 June 2015
- Published by Springer Nature in Cell & Bioscience
- Vol. 5 (1) , 1-10
Open AccessLeishmaniases diagnosis: an update on the use of immunological and molecular tools
Leishmaniases are caused by obligate intracellular protozoan parasites of the genus Leishmania. They cause a spectrum of diseases, most notably visceral (VL), cutaneous (CL), and mucosal (ML) leishmaniasis, which affect millions of people around the world, each year. Despite scientific advances, leishmaniases cases are expanding, constituting an important public health problem. Immunological and molecular diagnostic tools have been increasingly applied for the early detection of these parasitic infections, since the existence of limitations in clinical and parasitological examinations may provide false results, thus interfering in epidemiological research and diseases control. Although there is a great diversity of available immunological assays, important common deficiencies persist, which explains the current exploration of the molecular biology in research fields, especially the Polymerase Chain Reaction (PCR) and its variants, such as real-time quantitative PCR. However, in the last years, significant results have also been reached inside of immunological context (especially by Flow Cytometry), for humans and dogs, demonstrated by research works of the New and Old worlds. In spite of their potential to clarify and minimize the present global situation of the diseases, the implementation of molecular or immunological innovative reference assays for VL and CL at health services is still a challenge due to several reasons, including lack of standardization among laboratories and structural concerns. In this article we bring classical and current information about technological advances for the immunological and molecular leishmaniases diagnosis, their features, and applications.
- 27 November 2014
- Published by Springer Nature in Molecular Biotechnology
- Vol. 57 (4) , 318-324
Inclusion of Quality Controls on Leishmaniases Molecular Tests to Increase Diagnostic Accuracy in Research and Reference Laboratories
Early detection of leishmaniases and prompt institution of treatment are paramount for individuals and communities affected by these diseases. To overcome the remaining limitations inherent to molecular methods currently used and to ensure the accuracy of results in leishmaniases diagnosis, two triplex polymerase chain reaction (PCR) assays with quality controls for the reactions were developed. Validity indicators were assessed in 186 dog blood samples from endemic areas in Brazil. The level of agreement between the new tools and their singleplex protocols was assessed by kappa analysis. The triplex PCR for visceral leishmaniasis showed sensitivity (S) = 78.68 %, specificity (E) = 85.29 %, and efficiency (e) = 81.05 %. The cutaneous leishmaniasis protocol showed S = 97.29 %, E = 79.16 %, and e = 90.16 %. Both protocols showed good agreement with gold standards. These new tools enable, in a single reaction, the diagnosis of the diseases and the evaluation of the sample quality and DNA extraction process, thus reducing the cost of reagents and avoiding the eventual need for collecting a second sample.
- 27 November 2014
- Published by Springer Nature in Molecular Biotechnology
- Vol. 57 (4) , 318-324
Inclusion of Quality Controls on Leishmaniases Molecular Tests to Increase Diagnostic Accuracy in Research and Reference Laboratories
Early detection of leishmaniases and prompt institution of treatment are paramount for individuals and communities affected by these diseases. To overcome the remaining limitations inherent to molecular methods currently used and to ensure the accuracy of results in leishmaniases diagnosis, two triplex polymerase chain reaction (PCR) assays with quality controls for the reactions were developed. Validity indicators were assessed in 186 dog blood samples from endemic areas in Brazil. The level of agreement between the new tools and their singleplex protocols was assessed by kappa analysis. The triplex PCR for visceral leishmaniasis showed sensitivity (S) = 78.68 %, specificity (E) = 85.29 %, and efficiency (e) = 81.05 %. The cutaneous leishmaniasis protocol showed S = 97.29 %, E = 79.16 %, and e = 90.16 %. Both protocols showed good agreement with gold standards. These new tools enable, in a single reaction, the diagnosis of the diseases and the evaluation of the sample quality and DNA extraction process, thus reducing the cost of reagents and avoiding the eventual need for collecting a second sample.
- Open Access
- 1 January 2014
- Published by Springer Nature in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 20 (1) , 16
Tracking false-negative results in molecular diagnosis: proposal of a triplex-PCR based method for leishmaniasis diagnosis
Molecular biological methods have become increasingly relevant to the diagnosis and control of infectious diseases, such as leishmaniasis. Since various factors may affect the sensitivity of PCR assays, including DNA yield and purity, an optimal extraction method is pivotal. Losses of a parasite's DNA during extraction may significantly impair its detection by PCR and lead to false-negative results. This study proposes a triplex PCR assay targeting the parasite's DNA, an external control (pUC18) and an internal control (G3PD) for accurate diagnosis of leishmaniasis. Two primer pairs were designed to detect the plasmid pUC18 and a triplex PCR assay targeting the Leishmania braziliensis kinetoplast DNA, the external control and the internal control was standardized. The triplex PCR assay was assessed for its ability to detect the three target DNA fragments simultaneously. PCR products from pUC18 DNA resulted in bands of 368 (P1) and 316 (P2) base pairs (bp). The triplex PCR optimized with the chosen external control system (P1) allowed the simultaneous detection of the internal control (G3PD - 567 bp) as well as of small quantities (10 pg) of the target parasite's DNA, detected by amplification of a 138 bp product. The new tool standardized herein enables a more reliable interpretation of PCR results, mainly by contributing to quality assurance of leishmaniasis diagnosis. Furthermore, after simple standardization steps, this protocol could be applied to the diagnosis of other infectious diseases in reference laboratories. This triplex PCR enables the assessment of small losses during the DNA extraction process, problems concerning DNA degradation (sample quality) and the detection of L. braziliensis kDNA.
- 1 January 2014
- Published by Springer Nature in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 20 (1) , 16
Open AccessTracking false-negative results in molecular diagnosis: proposal of a triplex-PCR based method for leishmaniasis diagnosis
Molecular biological methods have become increasingly relevant to the diagnosis and control of infectious diseases, such as leishmaniasis. Since various factors may affect the sensitivity of PCR assays, including DNA yield and purity, an optimal extraction method is pivotal. Losses of a parasite's DNA during extraction may significantly impair its detection by PCR and lead to false-negative results. This study proposes a triplex PCR assay targeting the parasite's DNA, an external control (pUC18) and an internal control (G3PD) for accurate diagnosis of leishmaniasis. Two primer pairs were designed to detect the plasmid pUC18 and a triplex PCR assay targeting the Leishmania braziliensis kinetoplast DNA, the external control and the internal control was standardized. The triplex PCR assay was assessed for its ability to detect the three target DNA fragments simultaneously. PCR products from pUC18 DNA resulted in bands of 368 (P1) and 316 (P2) base pairs (bp). The triplex PCR optimized with the chosen external control system (P1) allowed the simultaneous detection of the internal control (G3PD - 567 bp) as well as of small quantities (10 pg) of the target parasite's DNA, detected by amplification of a 138 bp product. The new tool standardized herein enables a more reliable interpretation of PCR results, mainly by contributing to quality assurance of leishmaniasis diagnosis. Furthermore, after simple standardization steps, this protocol could be applied to the diagnosis of other infectious diseases in reference laboratories. This triplex PCR enables the assessment of small losses during the DNA extraction process, problems concerning DNA degradation (sample quality) and the detection of L. braziliensis kDNA.